Cancer pharmacogenomics: current and future applications
- 27 January 2003
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1603 (2) , 99-111
- https://doi.org/10.1016/s0304-419x(03)00003-9
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- The molecular outlookNature, 2002
- Molecular Monitoring of Bleomycin-Induced Pulmonary Fibrosis by cDNA Microarray-Based Gene Expression ProfilingBiochemical and Biophysical Research Communications, 2001
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Recommendation for Caution with Irinotecan, Fluorouracil, and Leucovorin for Colorectal CancerNew England Journal of Medicine, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Diagnostic analysis, clinical importance and molecular basis of dihydropyrimidine dehydrogenase deficiencyTrends in Pharmacological Sciences, 1995
- Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in miceEuropean Respiratory Journal, 1994
- Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemiaThe Journal of Pediatrics, 1991
- Kinetic analysis of the in vitro binding of radioactive cis- and trans-dichlorodiammineplatinum(II) to DNAChemico-Biological Interactions, 1980